Helen of Troy Ltd. has closed its deal to acquire the PUR water purification product business from Procter & Gamble Co. The company said Tuesday that it projects PUR brand sales at about $110 million annually and that the acquisition will be immediately accretive to earnings.
Actavis Group has started shipping Clobetasol Propionate Shampoo and Clobetasol Propionate Lotion, indicated for the treatment of eczema and psoriasis. The company said Tuesday that the products are generic equivalents to Galderma’s Clobex Shampoo and Clobex Topical Lotion.
Shlomo Yanai, president and chief executive officer of Teva Pharmaceutical Industries Ltd., plans to retire in May, and the company has named Jeremy Levin, a former senior executive at Bristol-Myers Squibb to succeed him.
Sabona of London Unlimited Inc. has rolled out a selection of its magnetic and copper bracelets and other products at select Rite Aid drug stores.
While the coming of the new year leads many people to formulate resolutions, it spurs some others to resolve an important issue — paternity, according to a survey commissioned by Identigene.
Mylan Inc. has announced the rollout of two new generic drugs, including medications for high blood pressure and epilepsy. The company said Tuesday that its subsidiary Mylan Pharmaceuticals Inc.
Perrigo Co. has gained final approval from the Food and Drug Administration for desloratadine tablets (5 mg), an allergy medication.
CutisPharma Inc. has extended its FIRST Magic Mouthwash line with four- and six-ounce BLM compounding kits.
Amneal Pharmaceuticals has launched what it said is the first generic Felbamate oral suspension in 600 mg/5 ml strength. Amneal said Wednesday that the first-to-market product is an AB-rated, therapeutically equivalent alternative to Meda Pharmaceuticals’ Felbatol.
PuraMed BioScience Inc. is hatching plans for the national product launch of LipiGesic M, its clinically tested migraine headache treatment.
Prestige Brands Holdings Inc. plans to acquire 17 over-the-counter pharmaceutical brands sold in North America from GlaxoSmithKline in $660 million cash deal.
Amgen and Watson Pharmaceuticals Inc. plan to collaborate on the development and global commercialization of several oncology antibody biosimilar medicines.
Jeff Berry has resigned his position as chief financial officer at Physicians Formula Holdings Inc. The cosmetics and skin care product maker said Wednesday that Berry is leaving the company "to pursue other professional interests" and is slated to exit his post on Jan. 13.
Germany-based Sebamed skin care products are slated to hit shelves at CVS/pharmacy next year. Physician Laboratories Inc., the U.S. distributor of Sebamed, said Tuesday that the products will be carried in 7,300 CVS stores starting in mid-January.
Stacey Lelko has joined pharmacy-based patient care service provider Mirixa Corp. as vice president of sales and business development. Mirixa said Tuesday that Lelko will lead its national sales team and develop strategic partner relationships.
Energizer Personal Care said its Schick brand will "revolutionize" women’s shaving with next year’s introduction of the Hydro Silk razor. Energizer said Monday that the Schick Hydro Silk razor provides an extra level of care for the skin by replacing moisture that shaving can take away.
